a near-significant trendP =0.07
The risk of CV diseases showed only a near-significant trend when therapy duration of at least 30 days (or all three strata) was assessed collectively for risk analysis (OR=1.02%, 95% CI=1.00–1.04, P =0.07).
The risk of CV diseases showed only a near-significant trend when therapy duration of at least 30 days (or all three strata) was assessed collectively for risk analysis (OR=1.02%, 95% CI=1.00–1.04, P =0.07).
No OR values in all strata of treatment duration were associated with statistical significance; when treatment duration of 30 days and more was all considered for risk analysis, the overall OR (95% CI) for GI bleeding was 1.27 (0.98–1.65) with a P -value of 0.07, only approaching borderline significance.